memantine and taurine

memantine has been researched along with taurine in 11 studies

Research

Studies (11)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (9.09)18.2507
2000's8 (72.73)29.6817
2010's2 (18.18)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Kornhuber, J; Spanagel, R1
Mahal, B; Parsons, C; Pestel, E; Putzke, J; Rammes, G; Schadrack, J; Spanagel, R; Spielmanns, P; Zieglgänsberger, W1
Bespalov, A; Danysz, W; Kashkin, V; Malyshkin, A; Neznanova, O; Sukhotina, I; Zakharova, E1
Chawla, PS; Kochar, MS1
Borges, S; Flockhart, D; Preskorn, SH1
Howland, RH1
Melnikova, I1
Spangler, JG1
Bochenski, M; Kotlinska, J1
Gibula-Bruzda, E; Koltunowska, D; Kotlinska, JH1
Bhakoo, KK; Duytschaever, H; Garnell, JF; Grandjean, J; Sekar, S; Seramani, S; Su, H; Ver Donck, L; Willems, R1

Reviews

3 review(s) available for memantine and taurine

ArticleYear
What's new in clinical pharmacology and therapeutics.
    WMJ : official publication of the State Medical Society of Wisconsin, 2006, Volume: 105, Issue:3

    Topics: Acamprosate; Amyloid; Azabicyclo Compounds; Daptomycin; Diphosphonates; Drug Approval; Humans; Ibandronic Acid; Influenza Vaccines; Islet Amyloid Polypeptide; Ketolides; Lanthanum; Memantine; Pharmacology, Clinical; Piperazines; Rifamycins; Rifaximin; Scopolamine Derivatives; Taurine; Tiotropium Bromide; United States; United States Food and Drug Administration

2006
Clinically relevant pharmacology of neuropsychiatric drugs approved over the last three years: part I.
    Journal of psychiatric practice, 2006, Volume: 12, Issue:4

    Topics: Acamprosate; Alcohol Deterrents; Alcoholism; Alzheimer Disease; Brain; Dopamine Agents; Humans; Memantine; Mental Disorders; Psychotropic Drugs; Taurine

2006
Glutamate-modulating drugs & the treatment of mental disorders.
    Journal of psychosocial nursing and mental health services, 2007, Volume: 45, Issue:1

    Topics: Acamprosate; Amantadine; Cycloserine; Glutamic Acid; Humans; Ketamine; Lamotrigine; Memantine; Mental Disorders; Psychotropic Drugs; Riluzole; Taurine; Triazines

2007

Other Studies

8 other study(ies) available for memantine and taurine

ArticleYear
[Glutamate receptor agonists and alcohol dependence. Preclinical findings].
    Der Nervenarzt, 1999, Volume: 70, Issue:5

    Topics: Acamprosate; Alcohol Deterrents; Alcoholism; Animals; Chronic Disease; Disease Models, Animal; Humans; Memantine; Rats; Rats, Inbred Strains; Receptors, N-Methyl-D-Aspartate; Secondary Prevention; Taurine

1999
The anti-craving compound acamprosate acts as a weak NMDA-receptor antagonist, but modulates NMDA-receptor subunit expression similar to memantine and MK-801.
    Neuropharmacology, 2001, Volume: 40, Issue:6

    Topics: Acamprosate; Alcohol Deterrents; Animals; Brain; Cell Line; Dizocilpine Maleate; Dose-Response Relationship, Drug; Excitatory Amino Acid Agonists; Excitatory Amino Acid Antagonists; Female; Humans; Male; Memantine; N-Methylaspartate; Neurons; Rats; Rats, Wistar; Receptors, N-Methyl-D-Aspartate; Taurine; Xenopus

2001
The NMDA receptor channel blocker memantine and opioid receptor antagonist naltrexone inhibit the saccharin deprivation effect in rats.
    Behavioural pharmacology, 2004, Volume: 15, Issue:4

    Topics: Acamprosate; Animals; Choice Behavior; Ethanol; Male; Memantine; Naloxone; Naltrexone; Narcotic Antagonists; Rats; Rats, Wistar; Receptors, N-Methyl-D-Aspartate; Saccharin; Substance Withdrawal Syndrome; Sweetening Agents; Taurine

2004
Therapies for Alzheimer's disease.
    Nature reviews. Drug discovery, 2007, Volume: 6, Issue:5

    Topics: Alzheimer Disease; Alzheimer Vaccines; Amyloid beta-Peptides; Amyloid Precursor Protein Secretases; Cholinesterase Inhibitors; Clinical Trials as Topic; Excitatory Amino Acid Antagonists; GABA Agonists; Humans; Immunization; Memantine; Receptors, N-Methyl-D-Aspartate; Taurine

2007
NMDA receptor blockade: a novel avenue for tobacco intervention?
    Medical hypotheses, 2008, Volume: 70, Issue:5

    Topics: Acamprosate; Central Nervous System Stimulants; Humans; Memantine; Models, Biological; Models, Theoretical; Neurons; Nicotiana; Nicotine; Prefrontal Cortex; Receptors, N-Methyl-D-Aspartate; Smoking Cessation; Taurine

2008
The influence of various glutamate receptors antagonists on anxiety-like effect of ethanol withdrawal in a plus-maze test in rats.
    European journal of pharmacology, 2008, Nov-19, Volume: 598, Issue:1-3

    Topics: Acamprosate; Alcohol Deterrents; Animals; Anxiety; Behavior, Animal; Central Nervous System Depressants; Ethanol; Excitatory Amino Acid Antagonists; Male; Memantine; Pyridines; Quinolines; Rats; Rats, Wistar; Receptor, Metabotropic Glutamate 5; Receptors, Glutamate; Receptors, Metabotropic Glutamate; Substance Withdrawal Syndrome; Taurine; Thiazoles

2008
The influence of ionotropic and metabotropic glutamate receptor ligands on anxiety-like effect of amphetamine withdrawal in rats.
    Progress in neuro-psychopharmacology & biological psychiatry, 2013, Aug-01, Volume: 45

    Topics: Acamprosate; Amphetamine; Animals; Anxiety; Bridged Bicyclo Compounds; Dose-Response Relationship, Drug; Excitatory Amino Acid Agonists; Excitatory Amino Acid Antagonists; Ligands; Male; Memantine; Pyridines; Rats; Receptors, Ionotropic Glutamate; Receptors, Metabotropic Glutamate; Substance Withdrawal Syndrome; Taurine; Thiazoles

2013
Neuro-metabolite profiles of rodent models of psychiatric dysfunctions characterised by MR spectroscopy.
    Neuropharmacology, 2019, 03-01, Volume: 146

    Topics: Anhedonia; Animals; Choline; Depression; Disease Models, Animal; Excitatory Amino Acid Antagonists; Glutamic Acid; Glutamine; Hippocampus; Inositol; Magnetic Resonance Spectroscopy; Male; Memantine; Motor Activity; Rats; Rats, Wistar; Schizophrenia; Stress, Psychological; Sucrose; Taurine

2019
chemdatabank.com